MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

MCI reverters have a favorable cognitive prognosis and cortical integrity in Parkinson’s disease

SJ. Chung, Y-H. Park, YH. Sohn, J-M. Lee, PH. Lee (Seoul, Republic of Korea)

Meeting: 2019 International Congress

Abstract Number: 1672

Keywords: Dementia, Magnetic resonance imaging(MRI), Parkinsonism

Session Information

Date: Wednesday, September 25, 2019

Session Title: Cognition and Cognitive Disorders

Session Time: 1:15pm-2:45pm

Location: Agora 3 East, Level 3

Objective: To investigate whether reversion to cognitively normal status (CogN) is clinically relevant in Parkinson’s disease with mild cognitive impairment (PD-MCI).

Background: The concept of MCI is widely accepted as a transitional state between normal cognition and dementia not only in Alzheimer’s disease populations but also in patients with PD. However, not all patients with PD-MCI progress to dementia, and a considerable number of patients return to CogN during follow-up.

Method: 293 patients with PD-MCI underwent serial neuropsychological assessment 2-5 times (a mean interval, 1.5 years). Forty-six patients reverted to CogN (reverters) during follow-up, while the other 247 did not (non-reverters). We assessed the risk of cognitive worsening in PD-MCI reverters, non-reverters, and PD-CogN patients (n = 115). Additionally, we performed comparative analyses of cortical thickness, white matter integrity, and resting-state functional connectivity between de novo PD-MCI reverters (n = 17) and matched non-reverters (n = 34).

Results: PD-MCI reverters were younger, had higher frequencies of single-domain MCI type and amnestic type with retrieval failure, and showed better cognitive performance compared with non-reverters. PD-MCI reverters had a lower risk of dementia conversion relative to that in the non-reverters (hazard ratio, 11.6; p = 0.001). The risk of reconversion to MCI or progression to dementia in PD-MCI reverters was similar to that of cognitive worsening in PD-CogN patients. The reverter group exhibited greater cortical thickness in the right parahippocampal gyrus relative to the non-reverter group, while white matter integrity did not differ between the groups. Additionally, PD-MCI reverters exhibited less severely decreased functional connectivity in the default mode and executive control networks [figure 1].

Conclusion: This study demonstrated that PD-MCI reverters had relatively preserved structural and functional integrity and a favorable cognitive prognosis compared with those in the non-reverters, suggesting that cognitive defect and neurodegenerative burden are less severe in this group.

figure 1

References: N/A

To cite this abstract in AMA style:

SJ. Chung, Y-H. Park, YH. Sohn, J-M. Lee, PH. Lee. MCI reverters have a favorable cognitive prognosis and cortical integrity in Parkinson’s disease [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/mci-reverters-have-a-favorable-cognitive-prognosis-and-cortical-integrity-in-parkinsons-disease/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/mci-reverters-have-a-favorable-cognitive-prognosis-and-cortical-integrity-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley